Watson Pharmaceuticals Appoints Christopher W. Bodine to Board of Directors
Watson Pharmaceuticals, Inc. , a leader in generic and specialty branded pharmaceuticals, today announced the appointment of Christopher W. Bodine to its Board of Directors, effective immediately. The addition of Mr. Bodine expands Watson's Board to ten members, of whom nine are independent. Mr. Bodine's career spans 36 years with two of the nation's leading retail and healthcare companies and brings to Watson a significant chain drug industry background. [more...]
|
|
|
